Ibalizumab is a monoclonal antibody medication used to treat HIV infections. It is used in combination with other antiretroviral medications to treat HIV infection that is resistant to other treatments. It works by blocking the entry of HIV into certain cells in the body. It is administered as an intravenous infusion every two weeks. Common side effects include headache, nausea, and diarrhea.
Ibalizumab, sold under the brand name Trogarzo, is a medication used to treat HIV-1 infection . It is a humanized monoclonal antibody, which means it is a protein made in a laboratory that acts like a human immune system antibody. Ibalizumab works by attaching to the CD4 receptor on immune system cells. This prevents HIV from entering and infecting these cells. Ibalizumab is typically used in combination with other antiretroviral medications for people with HIV-1 infection who have not been able to control the virus with other medications. It is given by intravenous infusion (into a vein) every two weeks.